CompletedPhase 3NCT00004802

Phase III Randomized, Double-Blind, Placebo-Controlled Study of Dichlorphenamide for Periodic Paralyses and Associated Sodium Channel Disorders

Studying Hypokalemic periodic paralysis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
National Center for Research Resources (NCRR)
Principal Investigator
Jerry R. Mendell
Ohio State University
Intervention
dichlorphenamide(drug)
Enrollment
64 enrolled
Eligibility
10-75 years · All sexes
Timeline
1992

Collaborators

Ohio State University

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00004802 on ClinicalTrials.gov

Other trials for Hypokalemic periodic paralysis

Additional recruiting or active studies for the same condition.

See all trials for Hypokalemic periodic paralysis →

← Back to all trials